These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 27774025)

  • 21. Pharmacotherapies for sleep disturbances in Alzheimer's disease.
    McCleery J; Cohen DA; Sharpley AL
    Cochrane Database Syst Rev; 2014 Mar; (3):CD009178. PubMed ID: 24659320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating patients with moderate to severe Alzheimer's disease: implications of recent pharmacologic studies.
    Forchetti CM
    Prim Care Companion J Clin Psychiatry; 2005; 7(4):155-61. PubMed ID: 16163398
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Memantine for dementia.
    Areosa Sastre A; McShane R; Sherriff F
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003154. PubMed ID: 15495043
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Galantamine for Alzheimer's disease.
    Olin J; Schneider L
    Cochrane Database Syst Rev; 2002; (3):CD001747. PubMed ID: 12137632
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An evaluation of community-based cognitive stimulation therapy: a pilot study with an Irish population of people with dementia.
    Kelly ME; Finan S; Lawless M; Scully N; Fitzpatrick J; Quigley M; Tyrrell F; O'Regan A; Devane A
    Ir J Psychol Med; 2017 Sep; 34(3):157-167. PubMed ID: 30115146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive stimulation therapy in the Italian context: its efficacy in cognitive and non-cognitive measures in older adults with dementia.
    Capotosto E; Belacchi C; Gardini S; Faggian S; Piras F; Mantoan V; Salvalaio E; Pradelli S; Borella E
    Int J Geriatr Psychiatry; 2017 Mar; 32(3):331-340. PubMed ID: 27272538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.
    Standridge JB
    Clin Ther; 2004 May; 26(5):615-30. PubMed ID: 15220008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Cholinesterase Inhibitors Across All Stages of Alzheimer's Disease.
    Deardorff WJ; Feen E; Grossberg GT
    Drugs Aging; 2015 Jul; 32(7):537-47. PubMed ID: 26033268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003154. PubMed ID: 16034889
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying prognostic indicators for cognitive stimulation therapy for dementia: protocol for a systematic review and individual participant data meta-analysis.
    Crawley D; Saunders R; Buckman JEJ; Hui E; Walker R; Dotchin C; Spector A
    BJPsych Open; 2023 Apr; 9(3):e69. PubMed ID: 37066632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Risk-Benefit Assessment of Dementia Medications: Systematic Review of the Evidence.
    Buckley JS; Salpeter SR
    Drugs Aging; 2015 Jun; 32(6):453-67. PubMed ID: 25941104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Memantine for dementia.
    Areosa SA; Sherriff F; McShane R
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003154. PubMed ID: 15846650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.
    Tariot PN
    J Clin Psychiatry; 2006; 67 Suppl 3():15-22; quiz 23. PubMed ID: 16649847
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memantine for dementia.
    Areosa SA; Sherriff F
    Cochrane Database Syst Rev; 2003; (3):CD003154. PubMed ID: 12917950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Memantine for dementia.
    McShane R; Areosa Sastre A; Minakaran N
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003154. PubMed ID: 16625572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Time to Treatment Initiation in People With Alzheimer Disease: A Meta-Analysis of Randomized Controlled Trials.
    Tsoi KK; Hirai HW; Chan JY; Kwok TC
    J Am Med Dir Assoc; 2016 Jan; 17(1):24-30. PubMed ID: 26392193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive stimulation therapy as a sustainable intervention for dementia in sub-Saharan Africa: feasibility and clinical efficacy using a stepped-wedge design.
    Paddick SM; Mkenda S; Mbowe G; Kisoli A; Gray WK; Dotchin CL; Ternent L; Ogunniyi A; Kissima J; Olakehinde O; Mushi D; Walker RW
    Int Psychogeriatr; 2017 Jun; 29(6):979-989. PubMed ID: 28222815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug and Exercise Treatment of Alzheimer Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis of Effects on Cognition in Randomized Controlled Trials.
    Ströhle A; Schmidt DK; Schultz F; Fricke N; Staden T; Hellweg R; Priller J; Rapp MA; Rieckmann N
    Am J Geriatr Psychiatry; 2015 Dec; 23(12):1234-1249. PubMed ID: 26601726
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive stimulation therapy (CST) for dementia: a systematic review of qualitative research.
    Gibbor L; Yates L; Volkmer A; Spector A
    Aging Ment Health; 2021 Jun; 25(6):980-990. PubMed ID: 32252561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.